They hold blood products awaiting delivery to healthcare facilities, as well as samples for the EFS biobanks.
Depending on the case, the affected equipment was brought under control without any impact on the products, or it was shut down.
No health impact has been identified, and no blood products were lost.
The products in the affected equipment were plasma bags intended for transfusion and plasma bags intended for fractionation, the process used to manufacture medicines.
In this case, monitoring and alarm systems that the EFS operates itself made the difference.